As Teva wins U.S. approval for GSK Advair copy, main fight yet to come

LONDON (Reuters) - Israel's Teva Pharmaceutical Industries has won U.S. approval to market a copy of GlaxoSmithKline's best-selling Advair inhaler, although the real battle is still to come.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news